Chromosome Examinations in Patients on Lithium Carbonate

Authors:
  • LJLissy F. Jarvik
    Lissy F. Jarvik
  • NBNutan P. Bishun
    Nutan P. Bishun
  • HBHerman Bleiweiss
    Herman Bleiweiss
  • TKTakashi Kato
    Takashi Kato
  • EMEmilia Moralishvili
    Emilia Moralishvili

Abstract
Because of a report in the literature that three patients on lithium carbonate showed chromosome damage in excess of that seen in controls, peripheral blood cultures were set up from 16 manic-depressive patients who had taken lithium carbonate for periods of two weeks to over two years (seven of them for one year or more), from four manic-depressive patients on placebo, and from ten control subjects. Even though the highest average frequency of breaks occurred in the lithium carbonate group (3.3%), the value corresponded to the means (1.9% to 4.3%) generally observed in our laboratory and the difference between the lithium carbonate group and the present controls (1.5% breaks) did not reach statistical significance.